Log in to search using one of your social media accounts:


Real-World Economic Burden Associated with Transplantation-Related Complications

Hematopoietic cell transplantation (HCT) is a potentially curative treatment for patients with high-risk hematologic malignancies [1,2]. Common indications for HCT in adults include acute myelogenous leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, chronic myelogenous leukemia, chronic lymphocytic leukemia, acute lymphoblastic leukemia, lymphoma, multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphoma, and certain solid tumors [2].
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research

Related Links:

More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Biology | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Myeloproliferative Disorders | Non-Hodgkin's Lymphoma | Transplants